Edan, Gilles http://orcid.org/0000-0002-9641-6734
Le Page, Emmanuelle
Article History
Accepted: 6 September 2023
First Online: 19 September 2023
Declarations
:
: No specific funding was recieved for the preparation of this review.
: Both authors were involved as investigators in most of the phase 3 trials of approved DMDs and our institution received occasionally research grants from the industrials : Biogen, merck, Teva, Bayer, Novartis, Sanofi and Roche.
: Not applicable.
: Not applicable.
: This manuscript has no associated data.
: Both authors contributed to this review.
: Not applicable.